All listings for this product
About this product
- DescriptionThis book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechlogy from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialization of biological inventions. The author also considers the contradictions between the Supreme Court of Canada rulings in respect of the Harvard oncomouse, and genetically modified cala. He explores law, policy, and practice in both Australia and New Zealand in respect to gene patents and n-coding DNA. This study charts the rebellion against the European Union Biotechlogy Directive - particularly in respect of Myriad Genetics' BRCA1 and BRCA2 patents, and stem cell patent applications. The book also considers whether patent law will accommodate frontier techlogies - such as bioinformatics, haplotype mapping, proteomics, pharmacogemics, and natechlogy. Intellectual Property and Biotechlogy will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and techlogy transfer specialists.
- Author BiographyMatthew Rimmer, Professor of Intellectual Property and Innovation Law, Faculty of Law, Queensland University of Technology (QUT), Australia
- Author(s)Matthew Rimmer
- PublisherEdward Elgar Publishing Ltd
- Date of Publication28/02/2011
- SubjectEngineering & Technology: Textbooks & Study Guides
- Place of PublicationCheltenham
- Country of PublicationUnited Kingdom
- ImprintEdward Elgar Publishing Ltd
- Width234 mm
- Height156 mm
Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $79.89Trending at AU $90.22
- AU $29.85Trending at AU $30.26
- AU $18.30Trending at AU $24.34
- AU $31.46Trending at AU $40.54
- AU $22.32Trending at AU $36.99
- AU $40.77Trending at AU $41.34
- AU $16.90Trending at AU $20.15
This item doesn't belong on this page.
Thanks, we'll look into this.